ACADIA Pharmaceuticals Inc (ACAD)
17.56
+0.36
(+2.09%)
USD |
NASDAQ |
Nov 08, 15:42
ACADIA Pharmaceuticals Revenue (Annual): 726.44M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 726.44M |
| December 31, 2022 | 517.24M |
| December 31, 2021 | 484.14M |
| December 31, 2020 | 441.76M |
| December 31, 2019 | 339.08M |
| December 31, 2018 | 223.81M |
| December 31, 2017 | 124.90M |
| December 31, 2016 | 17.33M |
| December 31, 2015 | 0.061M |
| December 31, 2014 | 0.12M |
| December 31, 2013 | 1.145M |
| December 31, 2012 | 4.907M |
| Date | Value |
|---|---|
| December 31, 2011 | 2.067M |
| December 31, 2010 | 42.14M |
| December 31, 2009 | 6.399M |
| December 31, 2008 | 1.59M |
| December 31, 2007 | 7.555M |
| December 31, 2006 | 8.133M |
| December 31, 2005 | 10.96M |
| December 31, 2004 | 4.604M |
| December 31, 2003 | 7.378M |
| December 31, 2002 | 6.276M |
| December 31, 2001 | 3.714M |
| December 31, 2000 | 4.312M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
339.08M
Minimum
2019
726.44M
Maximum
2023
501.73M
Average
484.14M
Median
2021
Revenue (Annual) Benchmarks
| Biogen Inc | 9.836B |
| Madrigal Pharmaceuticals Inc | -- |
| Supernus Pharmaceuticals Inc | 607.52M |
| Geovax Labs Inc | -- |
| Myomo Inc | 19.24M |